| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/17/2008 | WO2008015697A3 A process for manufacturing an herbal composition for relieving pain from joints and bones |
| 04/17/2008 | WO2007138381A3 Phosphonated oxazolidinones and uses thereof for the prevention and treatment of bone and joint infections |
| 04/17/2008 | WO2007134326A3 Methods for treating autoimmune diseases using a taci-ig fusion molecule |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090823 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 04/17/2008 | US20080090821 Improved solubility, lower tendency to bind to plasma proteins and greater activity especially in serum-based assay systems; remodeling of heart after myocardial infarction; atherosclerosis; 2-[4-(4-Fluorophenoxy)benzenesulfonyl]-6-(2-piperidin-1-ylethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid |
| 04/17/2008 | US20080090818 (4-Morpholin-4-yl-phenyl)-[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]-amine; mitogen-activated protein kinase and matrix metallo proteinase inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090813 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090786 Atherosclerosis; ethyl (E)-2-(4-hydroxy-3-methoxyphenyl)vinyl-phosphonofluoridoate; fluorination of organophosphorus compounds, including organothiophosphorus compounds, to form corresponding fluoro(thio)phosphorus compounds |
| 04/17/2008 | US20080090784 Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it |
| 04/17/2008 | US20080090768 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080089883 Antisense oligonucleotides for prevention and/or treatment of infection, asthma, skin, inflammatory and/or autoimmune disorders |
| 04/17/2008 | US20080089871 Treating bone disorder in animal via propagation and implantation of chondrocytes into defective tissue area; wound healing agents; tissue repair and engineering |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911760A1 Xanthine oxidase inhibitor |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911744A1 Tryptophan derivative and use thereof |
| 04/16/2008 | EP1911743A1 Cyclic amine compound |
| 04/16/2008 | EP1911446A2 The use of PPAR-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
| 04/16/2008 | EP1910517A2 Method for isolating stem cells from cryopreserved dental tissue |
| 04/16/2008 | EP1910367A2 Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| 04/16/2008 | EP1909821A2 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1349559B1 Compositions for inducing secretion of insulin-like growth factor-1 |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | CN101163495A Use |
| 04/16/2008 | CN101163490A Artificial cerebrospinal fluid |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161281A A Chinese medicine liniment for treating cervical spondylosis, lumbar disease and its preparing method |
| 04/16/2008 | CN101161276A Nebula pressurized spray for treating rehabilitation of exogenous injury, empyrosis and bone fracture as well as its preparing method |
| 04/16/2008 | CN101161274A A Chinese medicine composition for treating gout |
| 04/16/2008 | CN101161273A A Chinese patent medicine for treating catagmat |
| 04/16/2008 | CN101161261A A Chinese medicine for treating osteoproliferation rheumatalgia |
| 04/16/2008 | CN101161251A On-off total saponin as well as its extracting method and application |
| 04/16/2008 | CN101161249A Method for extracting original mesenchyma and hematopoiesis trunks/ancestral cell from caesarean birth placenta for treating medulla scathe |
| 04/16/2008 | CN100381461C Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381435C Extractive of general flavone from blackberry lily, preparation method and application in preparing medication |
| 04/16/2008 | CN100381148C Medicine for treating internal bone wound |
| 04/16/2008 | CN100381140C Medicine for treating rheumatic disease, rheumatoid disease and other diseases and its preparing method |
| 04/16/2008 | CN100381128C Inclusion compound of ants supercritical extracts and preparation process thereof |
| 04/16/2008 | CN100381121C New use of linolenic acid in preparation of anti arthrolithiasis medicine or health care food |
| 04/16/2008 | CN100381066C Method for preparing bone-strengthening kidney-benefiting fatigue-alleviating milk powder with micron deer bone powder, dragon's bone powder, pine pollen and king solomonseal rhizome powder |
| 04/15/2008 | US7358376 Substituted Thiophene compounds |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358272 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating cancer, especially various types of leukemia |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358227 Synergistic mixture of at least two recombinant bone morphogenetic protein monomers generated by contacting said the monomers with urea to prevent dimerization; slow release biodegradable glycolic acid-lactic acid copolymer |
| 04/15/2008 | US7358224 Class III SLRP agonists for the reduction of blood vessel formation |
| 04/15/2008 | US7357929 Placental growth factor as a target for the treatment of osteoporosis |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/15/2008 | CA2323239C Novel matrix metalloproteinase inhibitors and down-regulators |
| 04/10/2008 | WO2008042968A2 Di-fluoro containing compounds as cysteine protease inhibitors |
| 04/10/2008 | WO2008042926A1 Cyclic modulators of chemokine receptor activity |
| 04/10/2008 | WO2008042925A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/10/2008 | WO2008041774A1 Sustained-release preparation having bone conduction ability |
| 04/10/2008 | WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 04/10/2008 | WO2008041118A2 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| 04/10/2008 | WO2008040993A1 Pharmaceutical formulation of risedronate |
| 04/10/2008 | WO2007061861A3 High-potency sweetener composition for treatment and/or prevention of osteoporosis and compositions sweetened therewith |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085917 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isoquinoline besylate salt, preparation and therapeutic use thereof |
| 04/10/2008 | US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof |
| 04/10/2008 | US20080085887 Hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy; e.g. (R)-3-(1-(3,4-difluorophenyl) propan-2-yl)-2-(3-hydroxypyridin-2-yl) 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one |
| 04/10/2008 | US20080085322 Administering composition of beeswax and fatty acid-containing oil, and sterol; nutraceuticals; enhanced proliferation of hematopoietic cells and immune functions of the body |
| 04/10/2008 | US20080085280 Using monoclonal antibody specific to bacterial ectodomain as tool in prevention and treatment of pancreatic, kidney and inflammatory disorders |
| 04/10/2008 | CA2665141A1 Composition comprising crustacean gastrolith components and its use |
| 04/10/2008 | CA2664878A1 Di-fluoro containing compounds as cysteine protease inhibitors |
| 04/10/2008 | CA2663436A1 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
| 04/09/2008 | EP1908466A1 Substituted propanamide derivative and pharmaceutical composition containing the same |
| 04/09/2008 | EP1907392A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 04/09/2008 | EP1907368A1 2-cyano-pyrimidines and -triazines as cysteine protease inhibitors |
| 04/09/2008 | EP1907362A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1906924A1 Bone marrow-directing drug delivery materials and their applications |
| 04/09/2008 | EP1511521B1 Strontium-apatite-cement-preparations and the use thereof |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN101160309A Novel imidazo [1, 5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/09/2008 | CN101160306A 苯并咪唑化合物 Benzimidazole compounds |
| 04/09/2008 | CN101157703A Adenine bisphosphonate and preparation method thereof and application in pharmaceutical preparations |
| 04/09/2008 | CN101156937A Medicine wine for curing rheumatism, gout and hydrocele disease |
| 04/09/2008 | CN101156920A Oral administration externally used drug for treating traumatic injury and its preparation method |